Krsnaa Diagnostics

Krsnaa Diagnostics’ board approved a preferential issue of up to 16.21 lakh warrants to chairman Rajendra Mutha and promoter-group company Krsna Diagnostics (Mumbai) Private Limited. Each warrant was convertible into one equity share over 18 months at the higher of the future regulatory floor price and ₹565; the minimum price implied proceeds of about ₹91.6 crore and full conversion would take the allottees’ combined holding from 27.11% to 30.57%. The company also reported consolidated operating revenue of ₹235.5 crore for the June 2026 quarter, up 22% year on year, while profit fell 19% to ₹16.6 crore. FY26 revenue was ₹772.8 crore and EBITDA margin was 28%. Rajasthan’s rollout had reached 27 mother labs and more than 800 collection centres, while the retail pathology business remained EBITDA-negative in FY26.

Powered by Tijori

Krsnaa Diagnostics reported consolidated revenue from operations of ₹235.5 crore for the quarter ended June 30, 2026, up from ₹193.0 crore a year earlier, while profit fell to ₹16.6 crore from ₹20.5 crore. The board approved a preferential issue of up to 16.21 lakh warrants to chairman and whole-time director Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited at a price of at least ₹565 each. Each warrant can be converted into one equity share within 18 months of allotment, and full subscription would take the two allottees’ disclosed stakes to 23.79% and 6.78%, respectively. At the end of FY26, Krsnaa had 27 Rajasthan mother labs and more than 800 collection centres, against revenue of ₹772.8 crore and an EBITDA margin of 28%.

Powered by Tijori

Krsnaa Diagnostics scheduled a board meeting for 13 August 2026 to approve unaudited standalone and consolidated results for the quarter ended 30 June and to evaluate a fund-raising proposal. The proposed securities could include equity shares, fully convertible warrants and other convertible or non-convertible instruments, including a possible preferential issue to the promoter or promoter group, subject to shareholder and regulatory approvals. Revenue was ₹7,728 million in FY26 and EBITDA margin was 28%. Government contracts accounted for about 80% of revenue, while radiology and pathology contributed roughly equal shares of FY26 revenue.

Powered by Tijori

July 23 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• KRSNAA DIAGNOSTICS - ENTERS AGREEMENT FOR CT SCAN FACILITIES AT 34 INSTITUTIONS IN HIMACHAL PRADESH

Source text: ID:nNSE8lTW7Q

Further company coverage: KRSN.NS

(([email protected];;))

May 25 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• KRSNAA DIAGNOSTICS MARCH-QUARTER CONSOL NET PROFIT 417.2 MILLION RUPEES

• KRSNAA DIAGNOSTICS MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.93 BILLION RUPEES

• KRSNAA DIAGNOSTICS - DECLARES DIVIDEND OF 2 RUPEES PER SHARE

Source text: ID:nnAZN4SYE5I

Further company coverage: KRSN.NS

(([email protected];))

April 17 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• KRSNAA DIAGNOSTICS - APPOINTS CHANDRA PRAKASH SINGH AS INTERIM CHIEF FINANCIAL OFFICER EFFECTIVE APRIL 17, 2026

Source text: ID:nBSE7hKK5N

Further company coverage: KRSN.NS

(([email protected];;))

Jan 15 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• PAWAN DAGA RESIGNS AS CFO

Source text: ID:nBSE7Bk7n8

Further company coverage: KRSN.NS

(([email protected];))

Dec 12 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• KRSNAA DIAGNOSTICS - ISSUANCE OF DEBENTURES UP TO 4.30 BILLION RUPEES APPROVED

• KRSNAA DIAGNOSTICS - NCD ISSUANCE ON PRIVATE PLACEMENT BASIS

Source text: ID:nBSE7hgGch

Further company coverage: KRSN.NS

(([email protected];))

** Shares of Krsnaa Diagnostics KRSN.NS rises 4.1% to 771 rupees, their highest since April 29

** Medical diagnostics co and consortium partner TCIL received new contract from Rajasthan govt for providing lab services

** Co did not disclose financial details of the deal

** More than 197,000 shares traded, over twice the 30-day avg

** Stock down 12.8% YTD

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

** Shares of Krsnaa Diagnostics Ltd KRSN.NS rise as much as 7.8% to 845 rupees

** Diagnostic services co reports Q2 consol net profit rise of 87% y/y at ~196 mln rupees; rev ~20% higher

** Says, rev growth in the first half of FY2025 was driven by higher patient volume and tests counts amid competitive pricing

** More than 142,000 shares traded as of 10:42 a.m. IST, vs their 30-day moving avg of 128,154 shares

** KRSN last up 4.1%, adding to YTD gains of 15.6%

(Reporting by Meenakshi Maidas in Bengaluru)

(([email protected];))

Oct 25 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• SEPT-QUARTER CONSOL NET PROFIT 196 MILLION RUPEES

• SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.86 BILLION RUPEES

Further company coverage: KRSN.NS

(([email protected];))

** Shares of Krsnaa Diagnostics KRSN.NS up 4.4% to 875 rupees, log their second-biggest intraday pct gain in two weeks

** Diagnostic services provider approves acquisition of 23.53% stake in equity shares of Apulki Healthcare

** Co did not disclose the cost of acquisition

** Stock up 23% YTD

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

Sept 25 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• APPROVED INVESTMENT IN APULKI HEALTHCARE

• CO SHALL ACQUIRE 23.53% OF STAKE IN APULKI

Source text for Eikon: ID:nNSE1x2s1G

Further company coverage: KRSN.NS

(([email protected];;))

** Shares of Krsna Diagnostics KRSN.NS up ~ 5% at 672.70 rupees

** Co on Tuesday reported 24% Y/Y surge in Q1 profit after tax, while rev rose 22%

** Stk down 6.3% YTD, biggest drag among diagnostic stocks

** Peers Vijaya Diagnostic VIJA.NS up 18% YTD, Thyrocare THYO.NS up ~ 21%, Metropolis Health METP.NS up 23%, Dr Lal Path DLPA.NS up 23%

** KRSN, Thyrocare "strong buy" rated on average; METP, DLPA "hold" rated, while VIJA "buy" rated - LSEG

(Reporting by Sethuraman NR in Bengaluru)

(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))

Aug 6 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• KRSNAA DIAGNOSTICS JUNE-QUARTER CONSOL NET PROFIT 179.2 MILLION RUPEES

• KRSNAA DIAGNOSTICS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.70 BILLION RUPEES

Source text for Eikon: ID:nNSE1YFs5m

Further company coverage: KRSN.NS

(([email protected];))

BENGALURU, July 24 (Reuters) - ** Shares of Krsnaa Diagnostics KRSN.NS rise 4.7% to 678.4 rupees apiece

** Rise after the diagnostic services provider signs contract with Madhya Pradesh government to set up, operate, manage and maintain MRI scan machines in five hospitals in the state

** KRSN has not disclosed the size of the contract in its exchange filing

** Shares of KRSN down about 4% in 2024 so far - Exchange data

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463;))

July 23 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• SIGNING OF AGREEMENT FOR PROVIDING MRI SERVICES

Source text for Eikon: ID:nNSE64F4GJ

Further company coverage: KRSN.NS

(([email protected];;))

July 4 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• BHABHA ATOMIC RESEARCH CENTRE AWARDED TENDER TO CO

Source text for Eikon: ID:nBSE99X1vs

Further company coverage: KRSN.NS

(([email protected];))

** Shares of Krsnaa Diagnostics KRSN.NS rise as much as 4.8% to 627.35 rupees, last up 4.1%

** Systematix Institutional Equities initiates coverage of pathology and radiology diagnostics services provider with "buy" rating and PT at 841 rupees

** The PT represents a 40.5% premium to stock's last close

** Over the last 5 years, KRSN clocked 34% and 25% CAGR in revenue and net earnings, respectively - Systematix

** Brokerage estimates 30% and 47% CAGR in KRSN's revenue and net earnings, respectively, over FY24-FY26, led by utilization of its recently set up diagnostic centers and opening of new centers

** KRSN's revenue is split 57:43 between radiology and pathology, and we expect the mix to slightly lean in favour of radiology in future - Systematix

(Reporting by Ashish Chandra in Bengaluru)

(([email protected] (+91 7982114624))

** Shares of Krsnaa Diagnostics KRSN.NS up as much as 4% to 598 rupees; last up 2.7%

** Pathology and radiology diagnostics services provider said it has signed an agreement with the government of Maharashtra state to provide MRI and CT scan services in district hospitals

** More than 151,000 shares traded as of 1:33 p.m. IST, 1.7x the 30-day moving avg

** Including session's move, stock is down 16.3% YTD, while peer Vijaya Diagnostic Centre VIJA.NS is up 0.4%

(Reporting by Navamya Ganesh Acharya in Bengaluru)

(([email protected]; +91 8805175330 ;))

May 1 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• SIGNED AGREEMENT WITH HEALTH SERVICES AND MISSION DIRECTOR, GOVERNMENT OF MAHARASHTRA

• AGREEMENT FOR PROVIDING MRI AND CT SCAN SERVICES IN MAHARASHTRA IN DISTRICT HOSPITALS UNDER AUTHORITY

Source text for Eikon: ID:nBSE4lgJ3D

Further company coverage: KRSN.NS

(([email protected];;))

April 1 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• DY. COMMISSIONER OF INCOME TAX, PUNE ISSUED ASSESSMENT ORDER AND DEMAND NOTICE

• GETS TAX ORDER FOR DEMAND AT 196.3 MILLION RUPEES

Source text for Eikon: ID:nBSEbxx1xn

Further company coverage: KRSN.NS

(([email protected];))

March 14 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• KRSNAA DIAGNOSTICS LTD - RECEIPT OF CERTIFICATE OF ACCREDITATION FROM COLLEGE OF AMERICAN PATHOLOGISTS

Source text for Eikon: ID:nBSE7hkkLs

Further company coverage: KRSN.NS

(([email protected];))

** Shares of diagnostics services provider Krsnaa Diagnostics KRSN.NS fall as much as 7.7% to 663.25 rupees

** Stock sees biggest intraday pct loss since Sept. 12

** Co reported a near 32% fall in consolidated net profit of 105 mln rupees ($1.26 million)

** Total expenses rose nearly 37%, hit by input costs which rose more than two-fold

** More than 168,000 shares traded by 12:05 p.m. IST, vs 1.6x 30-day avg

** Stock currently down 3.8%, trimming YTD gains to 50%

($1 = 83.2110 Indian rupees)

(Reporting by Navamya Ganesh Acharya in Bengaluru)

(([email protected]; +91 8805175330 ;))

Nov 3 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• INDIA'S KRSNAA DIAGNOSTICS SEPT-QUARTER CONSOL NET PROFIT 105 MILLION RUPEES VERSUS 153.4 MILLION RUPEES

• KRSNAA DIAGNOSTICS SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.55 BILLION RUPEES VERSUS 1.23 BILLION RUPEES

Source text for Eikon: ID:nBSE8TbxvV

Further company coverage: KRSN.NS

(([email protected];))

** Shares of India's Krsnaa Diagnostics KRSN.NS up as much as 5.4% at 680 rupees, posting highest level since Feb 4, 2022

** Co seen rising for third consecutive session

** Confident of co's execution capabilities, believe sufficient scope for earnings upgrade, - brokerage JM Financial note

** KRSN'S guidance is overall better than we expected, says JM Financial; rates co "buy" with PT of 1,050 rupees

** Co shared its annual report with its shareholders on Sept. 2

** However, brokerage flags change in mix towards pathology, large-scale tender implementation could mean "subdued near term margin"

** More than 230,000 shares changed hands by 3:23 p.m. IST, 1.2x 30-day avg

** YTD stock has soared 47%

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

** Shares of Krsnaa Diagnostics KRSN.NS rise as much as 8.59% to 573 rupees

** Stock up 17% in two sessions after the diagnostics services provider reiterates guidance for fiscal 2024

** KRSN expects revenue growth of 30-35%; sees 3 bln rupees revenue contribution from a recent Rajasthan contract in fiscal 2025

** Brokerage JM Financial reiterates "buy" and raises target price to 960 rupees from 930 rupees

** JM says confident of KRSN's strong execution and sees scope for stock re-rating

** Trading volume is 477,908 shares as of 2:16 p.m. IST, nearly thrice the 30-day avg - Refinitiv data

** Stock up ~23% this year

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463))

July 28 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• CO AND NATIONAL HEALTH MISSION, ASSAM HAS SIGNED CONTRACT

• TENDER FOR ESTABLISHMENT, OPERATION, MAINTENANCE OF LABORATORY DIAGNOSTIC CENTRES

Source text for Eikon: ID:nBSE6pZqFv

Further company coverage: KRSN.NS

(([email protected];))

** Shares of diagnostic services provider Krsnaa Diagnostics KRSN.NS fall as much as 15.5% to 451.20 rupees, sharpest intraday pct loss since Oct 12, 2021

** Stock of KRSN hits lowest level since March 31, and on track for a seventh consecutive session of losses, if trend holds

** The National Health Mission in Rajasthan on Wednesday canceled letter of award for consortium of co with Telecommunications Consultants India TELO.NS nFWN39514B

** More than 306,000 shares change hands, 4.4x the 30-day avg, most active trading session since May 30

** Stock up 15.9% this year as of last close

(Reporting by Anisha Ajith in Bengaluru)

(([email protected];))

July 19 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:

• NATIONAL HEALTH MISSION, RAJASTHAN CANCELED LOA TO CONSORTIUM OF CO WITH TELECOMMUNICATIONS CONSULTANTS INDIA

• CO IN COLLABORATION WITH TELECOMMUNICATIONS CONSULTANTS INDIA TOOK LEGAL RECOURSE

Source text for Eikon: [ID:]

Further company coverage: KRSN.NS

(([email protected];))